Human cathelicidin LL-37 – Does it influence the homeostatic imbalance in mental disorders?

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Biosciences

• Publication date

  2018-04-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12038-018-9751-8PMID 29872020
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases.

  2017cited by this paper
• Cathelicidin (LL‐37) and human β2‐defensin levels of children with post‐infectious bronchiolitis obliterans

  2017cited by this paper
• Serum levels of peptide cathelicidin LL-37 in elderly patients with depression.

  2017cited by this paper
• Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia

  2016cited by this paper
• Host immune response to tuberculous meningitis.

  2015cited by this paper
• Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers

  2015cited by this paper
• Human antimicrobial peptide LL-37 induces glial-mediated neuroinflammation.

  2015cited by this paper
• Molecular Substrates of Schizophrenia: Homeostatic Signaling to Connectivity

  2015cited by this paper
• Diagnostic value of anti-microbial peptide, cathelicidin in congenital pneumonia

  2015cited by this paper
• Status of vitamin D, antimicrobial peptide cathelicidin and T helper-associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis

  2014cited by this paper
• Host defense peptides: front-line immunomodulators.

  2014cited by this paper
• Cathelicidin and human β-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis.

  2014cited by this paper
• Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.

  2013cited by this paper
• Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.

  2013cited by this paper
• Little Peptide, Big Effects: The Role of LL-37 in Inflammation and Autoimmune Disease

  2013influential reference
• Antimicrobial peptides and gut microbiota in homeostasis and pathology

  2013cited by this paper
• Defensins and LL-37: a review of function in the gingival epithelium.

  2013cited by this paper
• Neuroinflammation in schizophrenia especially focused on the role of microglia.

  2013cited by this paper
• Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.

  2012cited by this paper
• Modulation of Neutrophil Apoptosis by Antimicrobial Peptides

  2012cited by this paper
• Age and low levels of circulating vitamin D are associated with impaired innate immune function

  2012cited by this paper
• Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: a PET study with [11C]NNC112

  2012cited by this paper
• A comprehensive summary of LL-37, the factotum human cathelicidin peptide.

  2012influential reference
• Intestinal antimicrobial peptides during homeostasis, infection, and disease

  2012cited by this paper
• Expression of antimicrobial peptides in diabetic foot ulcer.

  2012cited by this paper
• Evaluation of the Ability of LL-37 to Neutralise LPS In Vitro and Ex Vivo

  2011cited by this paper
• Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

  2011cited by this paper
• Low serum levels of cathelicidin LL-37 in leprosy.

  2011cited by this paper
• Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability.

  2011cited by this paper
• Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients.

  2011cited by this paper
• Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis.

  2010cited by this paper
• Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET.

  2009cited by this paper
• Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis.

  2009cited by this paper
• Journal of Translational Medicine BioMed Central

  2009cited by this paper
• Increased α-Defensins as a Blood Marker for Schizophrenia Susceptibility*

  2008cited by this paper
• Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis.

  2007cited by this paper
• An Antimicrobial Cathelicidin Peptide, Human CAP18/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X71

  2006cited by this paper
• Human Cathelicidin LL-37 Is a Chemoattractant for Eosinophils and Neutrophils That Acts via Formyl-Peptide Receptors

  2006cited by this paper
• Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL‐37

  2005cited by this paper
• Induction of Keratinocyte Migration via Transactivation of the Epidermal Growth Factor Receptor by the Antimicrobial Peptide LL-371

  2005cited by this paper
• Cathelicidins, multifunctional peptides of the innate immunity

  2004cited by this paper
• An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

  2003cited by this paper
• Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection.

  2002cited by this paper
• Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells

  2000cited by this paper
• 5-HT1A and 5-HT2A Receptor mRNAs and Binding Site Densities Are Differentially Altered in Schizophrenia

  1996cited by this paper

• LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases

  2024cites this paper
• Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort

  2022cites this paper
• Systemic concentration of apelin, but not resistin or chemerin, is altered in patients with schizophrenia

  2020cites this paper
• In vitro cytokine synthesis in unstimulated and mitogen-stimulated peripheral blood mononuclear cells from individuals with schizophrenia

  2019cites this paper